# Efficacy of Metformin as add-on Therapy in Non-Diabetic Heart Failure Patients

> **NCT05177588** · PHASE4 · COMPLETED · sponsor: **Cairo University** · enrollment: 70 (actual)

## Conditions studied

- Heart Failure

## Interventions

- **DRUG:** Metformin Hydrochloride

## Key facts

- **NCT ID:** NCT05177588
- **Lead sponsor:** Cairo University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-07-21
- **Primary completion:** 2023-03-30
- **Final completion:** 2023-04-30
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2023-07-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05177588

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05177588, "Efficacy of Metformin as add-on Therapy in Non-Diabetic Heart Failure Patients". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT05177588. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*